Humana Stock Price, News & Analysis

Humana reported 2Q22 earnings per diluted common share of $5.48 (GAAP) and $8.67 (Adjusted), with year-to-date EPS at $12.77 (GAAP) and $16.70 (Adjusted). The company raised its FY 2022 EPS guidance to approximately $20.30 (GAAP) and $24.75 (Adjusted), reflecting a 20% growth over FY 2021. Membership growth in Medicare Advantage is projected between 150,000 to 200,000 members. Significant improvements were noted in medical cost trends, allowing for increased investments and a positive outlook for the upcoming enrollment period.

Humana Inc. (NYSE: HUM) is hiring approximately 300 seasonal Enrollment Representatives for remote work nationwide. This recruitment supports the upcoming Medicare Annual Election Period, from October 15 to December 7, 2022. The roles focus on assisting members with enrolling in Medicare Advantage and Prescription Drug Plans. Candidates with customer service experience will undergo virtual interviews starting in August, with positions beginning from early September to November. In addition to these seasonal roles, Humana continues to offer full-time opportunities across its organization.

Humana Foundation awarded 75 college scholarships totaling up to $3,000 each, benefiting children of Humana employees for the 2022-23 school year. Scholarships are renewable for three years, potentially totaling $12,000 per recipient. Winners were selected from 488 applicants based on academic achievement and leadership. Since 2001, the foundation has dispensed over $13 million to assist 1,591 students. The initiative aims to uplift families and foster community prosperity.

Humana Inc. (NYSE: HUM) will announce its financial results for the second quarter 2022 on July 27, 2022, at 6:30 a.m. Eastern time. A conference call will follow at 9:00 a.m. Eastern time to discuss the earnings and guidance for 2022. Participants can register in advance to join the call and access a webcast on Humana's Investor Relations page. The earnings report will include non-GAAP financial measures, with reconciliations provided in the release, available on the Investor Relations page.

athenahealth, Inc. has been awarded the 2022 KLAS Points of Light award, being the only EHR provider recognized for its collaboration case study with Humana and SC House Calls. This award is a testament to their successful partnerships aimed at reducing healthcare inefficiencies and improving patient outcomes. The initiative focuses on enhancing provider-payer interoperability and clinical data exchange, resulting in better care gap closure and improved provider satisfaction. The award was presented at the KLAS Payer/Provider Summit held on May 24-25 in Salt Lake City, Utah.

Humana Inc. announced it achieved the highest ranking in the 2022 U.S. Dental Plan Satisfaction Study by J.D. Power, excelling in plan cost, communication, and customer service experience.

The study evaluates customer satisfaction across five key factors including claims, communication, and plan coverage, with data collected from March to April 2022. Humana's commitment to enhancing customer experience and affordability is highlighted, reflecting their focus on whole health through a broad network of dental providers.

Humana Inc. (NYSE: HUM) has invested $4.6 million in community organizations across Ohio to address public health challenges and enhance the well-being of residents. Key beneficiaries include The Foodbank, Greater Cleveland Food Bank, and Mid-Ohio Food Collective, focusing on food security, housing, and maternal health. This initiative aligns with Humana's mission to provide holistic healthcare, as evidenced by its coverage of approximately 563,700 Ohioans through various health plans. Humana's commitment to Ohio also extends to a broader population health strategy aimed at improving community health outcomes.

Humana Inc. (NYSE: HUM) has transitioned its pharmacy services to the CenterWell brand, now encompassing CenterWell Pharmacy and CenterWell Specialty Pharmacy. This change reflects a commitment to enhancing patient-centered care and ensuring reliable pharmacy services. The new branding aims to streamline care experiences, providing holistic and personalized healthcare options. Existing services like Enclara Pharmacia and Humana Pharmacy Solutions will retain their original branding. This brand evolution is part of Humana's broader strategy to integrate healthcare services and improve health outcomes.